These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6716401

  • 1. Intensely potent morpholinyl anthracyclines.
    Acton EM, Tong GL, Mosher CW, Wolgemuth RL.
    J Med Chem; 1984 May; 27(5):638-45. PubMed ID: 6716401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
    Mosher CW, Wu HY, Fujiwara AN, Acton EM.
    J Med Chem; 1982 Jan; 25(1):18-24. PubMed ID: 7086816
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Models of preclinical studies of anthracyclines].
    Fizames C.
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [Abstract] [Full Text] [Related]

  • 9. Improved antitumor effects of 3'-deamino-3'-morpholino derivatives of pirarubicin.
    Ajito K, Ikeda D, Nosaka C, Komuro K, Kondo S, Takeuchi T.
    J Antibiot (Tokyo); 1990 Nov; 43(11):1464-70. PubMed ID: 2272921
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of new morpholino anthracyclines.
    Komeshima N, Tsuruo T, Umezawa H.
    J Antibiot (Tokyo); 1988 Apr; 41(4):548-53. PubMed ID: 3163685
    [Abstract] [Full Text] [Related]

  • 11. 3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
    Takahashi Y, Kinoshita M, Masuda T, Tatsuta K, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1982 Jan; 35(1):117-8. PubMed ID: 7068512
    [No Abstract] [Full Text] [Related]

  • 12. N-(2-hydroxyethyl)doxorubicin from hydrolysis of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin.
    Acton EM, Tong GL, Smith TH, Taylor DL, Streeter DG, Peters JH, Gordon GR, Filppi JA, Wolgemuth RL, Giuliani FC.
    J Med Chem; 1986 Oct; 29(10):2120-2. PubMed ID: 3761328
    [Abstract] [Full Text] [Related]

  • 13. Comparative cytotoxicities of various morpholinyl anthracyclines.
    Streeter DG, Taylor DL, Acton EM, Peters JH.
    Cancer Chemother Pharmacol; 1985 Oct; 14(2):160-4. PubMed ID: 3971481
    [Abstract] [Full Text] [Related]

  • 14. 3'-Hydroxyesorubicin halogenated at C-2'.
    Priebe W, Neamati N, Perez-soler R.
    J Antibiot (Tokyo); 1992 Mar; 45(3):386-93. PubMed ID: 1577666
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Doxorubicin analogues incorporating chemically reactive substituents.
    Farquhar D, Newman RA, Zuckerman JE, Andersson BS.
    J Med Chem; 1991 Feb; 34(2):561-4. PubMed ID: 1995877
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 3'-Hydroxyesorubicin. Synthesis and antitumor activity.
    Priebe W, Neamati N, Perez-Soler R.
    J Antibiot (Tokyo); 1990 Jul; 43(7):838-46. PubMed ID: 2387778
    [Abstract] [Full Text] [Related]

  • 19. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
    Cassinelli G, Rivola G, Ruggieri D, Arcamone F, Grein A, Merli S, Spalla C, Casazza AM, Di Marco A, Pratesi G.
    J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.